September 17, 2020 | In The Press

Featured in Forbes

“At Goodekind, a hemp-focused social enterprise launched in early 2020, co-owners Kayla Croft and Flip Croft-Caderao are intent on making CBG (cannabigerol), once dubbed “the Rolls Royce of cannabinoids,” accessible and affordable. The non-psychotropic cannabinoid generally appears in most cultivars in quantities of less than one percent, however some varieties contain up to 15 percent CBG, vastly reducing the amount of plant matter required to make products such as topicals and extracts.”